On the other hand, other studies have shown that JQ1 and other BET inhibitors attenuate Aβ-induced neuroinflammation, preserve neuronal viability, and reduce neuronal loss in models of AD [35,43,44]. This evidence concerns the gene DNER and Alzheimer disease.